Health ยท Cameroon

Cameroon's HIV Prevalence Falls to 2.6% as Biomedical Research Centre Marks 20 Years

Cameroon's HIV/AIDS prevalence now stands at an estimated 2.6%, down from 3.4%, a virologist said as the Chantal Biya International Reference Centre (CIRCB) marked 20 years. New infections and deaths have also fallen, though researchers are watching for antiretroviral resistance and funding cuts.

Cameroon's HIV/AIDS prevalence is estimated at 2.6%, down from 3.4% over a seven-year period, according to virologist Dr Joseph Fokam of the Chantal Biya International Reference Centre (CIRCB). He spoke as the centre celebrated its 20th anniversary from 9 to 12 November 2026.

Dr Fokam said annual new infections have dropped from 48,000 to 21,000, while yearly deaths linked to the disease have fallen from roughly 23,000 to fewer than 10,000. He described the trend as remarkable progress.

The anniversary comes amid new health and financial pressures. More than 90% of people on treatment in Cameroon now receive dolutegravir-based medicines, and the risk of resistance to antiretroviral drugs is a growing concern for researchers. Monitoring how well treatment works has therefore become a central task in ensuring sustainable care for patients.

The centre is also confronting a decline in public funding and international grants. In response, it is seeking to diversify its resources. A bilateral meeting held on the sidelines of the celebrations was intended to bring in new partners for health research and innovation. Pr Isidore Bikoko, described as a partner of the CIRCB, said health is central to the transformation of societies.

As it enters its third decade, the CIRCB says it intends to consolidate its scientific achievements, strengthen its research capacity and build lasting partnerships. The institution says it aims to adapt its work to future health and funding demands.

More reporting from Voice of Africans